More about

Biologic Therapy

News
November 23, 2021
1 min read
Save

Temporary interruption of biologics in plaque psoriasis generally safe, effective

Withdrawal and reinitiation of treatment with most biologic agents had minimal impact on efficacy in plaque psoriasis, according to a study.

News
November 11, 2021
2 min read
Save

Initial choice of biologic may affect persistence of therapy in IBD

Among patients with inflammatory bowel disease who received at least two biologic therapies, discontinuation of treatment appeared to vary based on initial treatment choice, according to data presented at the ACG Annual Scientific Meeting.

News
November 08, 2021
3 min read
Save

FROST: Biologics most common initial therapy for systemic JIA

FROST: Biologics most common initial therapy for systemic JIA

Initial biologic therapy is now the most common treatment for children with systemic juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry, according to data presented at ACR Convergence 2021.

News
November 08, 2021
3 min read
Save

'Starting biologics early' with DMARDs may boost polyarticular JIA outcomes at 2 years

'Starting biologics early' with DMARDs may boost polyarticular JIA outcomes at 2 years

Early, aggressive treatment with a biologic alongside a conventional DMARDs for juvenile idiopathic arthritis achieved clinically inactive disease at 24 months more frequently than other strategies, said a presenter at ACR Convergence 2021.

News
November 07, 2021
2 min read
Save

Serious infection-related hospitalizations drop for PsA despite uptick in biologic use

Serious infection-related hospitalizations drop for PsA despite uptick in biologic use

Hospitalizations for sepsis, skin and soft tissue infections and UTI among patients with psoriatic arthritis “significantly” decreased over a 5-year period despite a rising uptake in biologics, according to data presented at ACR Convergence 2021.

News
October 25, 2021
2 min read
Save

Biologic use in psoriasis may increase PsA incidence vs. phototherapy, oral therapies

Biologic use in psoriasis may increase PsA incidence vs. phototherapy, oral therapies

Patients with psoriasis who use biologics are more likely to develop psoriatic arthritis than those on other or no therapies, according to retrospective data published in the Annals of the Rheumatic Diseases.

News
September 27, 2021
1 min read
Save

Use of systemic corticosteroids linked with worse COVID-19 outcomes

Use of systemic corticosteroids linked with worse COVID-19 outcomes

In a new study, approved asthma biologics and systemic corticosteroids were not associated with an increased risk for SARS-CoV-2 infection, but use of systemic corticosteroids was linked with worse COVID-19 outcomes.

News
September 14, 2021
1 min read
Save

Biologics not associated with COVID-19 risk or mortality

Biologics not associated with COVID-19 risk or mortality

COVID-19 mortality was not increased in patients on immunosuppressive biologics, according to a study.

News
September 08, 2021
2 min read
Save

AAOS provides information on appropriate use of orthobiologics

AAOS provides information on appropriate use of orthobiologics

SAN DIEGO — With a rise in interest in orthobiologics, the American Academy of Orthopaedic Surgeons has developed tools to educate orthopedic surgeons on when it is appropriate to use orthobiologics in practice.

News
August 05, 2021
3 min read
Save

Expanding drug armamentarium offers 'light at the end of the tunnel' for patients with RA

Expanding drug armamentarium offers 'light at the end of the tunnel' for patients with RA

The advent of biologics and other immunomodulatory options provides hope for patients with rheumatoid arthritis, according to a speaker at the 2021 Rheumatology Nurses Society annual conference.

View more